CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

RyMed Technologies Announces New Study Highlighting Superiority of Antibacterial-Impregnated Needleless Connectors against Multidrug-Resistant "SUPERBUGS"

ConferencepositiveInVision-Plus CS®Positive
AI Analysis

Summary

RyMed Technologies announced independent laboratory study results showing InVision-Plus CS® antibacterial needleless connectors achieved 36-fold higher microbial kill efficiency against VRE compared to standard connectors. The data will be presented at AVA 2026.

Outcome Details

36-fold higher microbial kill efficiency against VRE compared to standard silicone connectors

Importance:4/10
Sentiment:
0.70
medical deviceinfection preventionlaboratory testingantimicrobialconference presentation

Read the original article

Published by PR Newswire Clinical Trials on July 24, 2026 6:00 PM

Read Original